Medicare Enrolled

Dr. Tony Mammen, MD

Optician · Arlington, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5005 S COOPER ST STE 250, Arlington, TX 76017
8663678768
In practice since 2007 (18 years)
NPI: 1194948356 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mammen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mammen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mammen

Dr. Tony Mammen is an optician in Arlington, TX, with 18 years in practice. Based on federal Medicare data, Dr. Mammen performed 2,258 Medicare services across 1,684 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mammen received a total of $5,932 from 42 pharmaceutical and/or device companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mammen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 28% volume in TX$ $5,932 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,258
Medicare services
Top 28% in TX for optician
1,684
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~125 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)531$88$288
Bladder ultrasound after voiding221$7$24
Blood draw (venipuncture)177$6$13
Automated urinalysis177$2$5
PSA test (prostate cancer screening)141$18$41
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique90$67$298
Diagnostic exam of bladder and urethra using an endoscope87$184$547
New patient office visit (45-59 min)83$117$377
Infectious disease DNA/RNA test71$30$110
Urinalysis, manual69$3$8
Psa (prostate specific antigen) measurement, free67$18$41
Yeast/candida DNA test60$34$325
Detection test by nucleic acid for herpes simplex virus, amplified probe technique60$34$184
Office visit, established patient (20-29 min)53$60$202
Basic metabolic blood panel49$8$19
Complete blood count (CBC), automated46$6$14
Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique30$34$79
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique30$34$79
Detection test by nucleic acid for herpes virus-6, amplified probe technique30$34$79
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique30$34$79
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique30$34$79
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique30$34$79
Office visit, established patient, complex (40-54 min)29$131$420
Complete laser fragmentation of prostate including control of bleeding using an endoscope22$638$1,842
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional19$18$53
Testosterone (hormone) level, total14$25$57
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope12$237$735
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
9.8% medium
89.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,932
Total received (2018-2024)
Avg $847/year across 7 years
Top 24% in TX for optician
42
Companies
199
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,818 (98.1%)
Scientific / Research
Research funding and grants
$114 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,889
2023
$818
2022
$745
2021
$628
2020
$615
2019
$822
2018
$414

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$1,350
Astellas Pharma US Inc
$615
Janssen Biotech, Inc.
$439
BIOTISSUE HOLDINGS, INC.
$373
Boston Scientific Corporation
$266
ABBVIE INC.
$263
C. R. Bard, Inc. & Subsidiaries
$220
Blue Earth Diagnostics Limited
$217
Teleflex LLC
$185
Myovant Sciences Inc.
$184
Axonics, Inc.
$142
Sun Pharmaceutical Industries Inc.
$137
Sumitomo Pharma America, Inc.
$129
NeoTract Inc.
$117
Endo Pharmaceuticals Inc.
$108
Dendreon Pharmaceuticals LLC
$100
Ferring Pharmaceuticals Inc.
$98
Coloplast Corp
$97
Merck Sharp & Dohme Corporation
$91
Janssen Scientific Affairs, LLC
$84
Olympus America Inc.
$82
AbbVie, Inc.
$70
Verity Pharmaceuticals Inc.
$52
Bayer Healthcare Pharmaceuticals Inc.
$50
Innovation Technologies Inc
$48
Antares Pharma, Inc.
$46
HealthTronics Mobile Solutions, LLC
$41
TOLMAR Pharmaceuticals, Inc.
$35
Agiliti Surgical, Inc.
$30
Clarus Therapeutics Inc.
$30
AngioDynamics, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$27
Amgen Inc.
$26
UroGen Pharma, Inc.
$24
UROVANT SCIENCES INC
$22
Duchesnay USA Incorporated
$18
GENZYME CORPORATION
$18
Myriad Genetic Laboratories, Inc.
$16
180 Medical, Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$14
Progenics Pharmaceuticals, Inc.
$13
PFIZER INC.
$11
Top 3 companies account for 40.5% of total payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · AVEED · Axonics · Axumin · BOTOX · Bulkamid · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GENTLECATH · IRRISEPT · Inlay · Isiris aStent Removal Device · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · Lupron Depot · MYRBETRIQ · Mobile Laser Services · NANOKNIFE · NEOX · NOCDURNA · Nubeqa · ORGOVYX · Olympus Cysto-Resection · Osphena · PROVENGE · PYLARIFY · Prolaris · Prolia · SpeediCath · Trelstar · UROLIFT · UroLift · VESICARE · XIAFLEX · XTANDI · Xofigo · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $263 per 100 Medicare services performed
Looking for a optician in Arlington?
Compare opticians in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
293
Per 100K population
13.7
County median income
$81,905
Nearest hospital
USMD HOSPITAL AT ARLINGTON L P
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mammen is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mammen experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mammen performed 531 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mammen receive payments from pharmaceutical companies?
Yes. Dr. Mammen received a total of $5,932 from 42 companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mammen's costs compare to other opticians in Arlington?
Dr. Mammen's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mammen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →